메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
ABOUT US
About us
History
BUSINESS
TB vaccine (QTP101)
COVID-19 vaccine (QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
IR
공시정보
공고
CONTACT US
KR
EN
SITE MAP
ABOUT US
About us
History
BUSINESS
TB vaccine(QTP101)
COVID-19 vaccine(QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
IR
공시정보
Careers
ABOUT US
About us
History
BUSINESS
TB vaccine (QTP101)
COVID-19 vaccine (QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
IR
공시정보
공고
Quratis
Tel : +82 2 866 0604 Fax : +82 2 867 0125 Email : info@quratis.com
CONTACT US
PR
Notice
Press
PR data
Tuberculosis News
Careers
NOTICE
Finalization of Licensing Agreement with IDRI (Jun 07, 2017)
관리자
|
2017-09-01
Hit
|
4,272
목록